AdvanSix Inc.

ASIX

NYSE

16.02

USD

+0.29(+1.84%)

As of today

Overview Financials Dividends Ratios Discussions Analysis

AdvanSix Inc. fundamentals

Overview Income Statement Balance Sheet Cash Flow

Key ratios

P/E Ratio

8.34

Price/Book

0.53

Debt/Equity

49.69%

Return on Equity

6.53%

Dividend Yield

4.00%

EBITDA

133.06M

AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.

Statements Highlights

AnnualQuarterly

Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Total Revenue	1,157,917,000	1,684,625,000	1,945,640,000	1,533,599,000	1,517,557,000
Gross Profit	133,748,000	274,122,000	314,479,000	165,088,000	152,936,000
Operating Income	0	191,137,000	226,731,000	69,550,000	58,913,000
Net Income	46,077,000	139,791,000	171,886,000	54,623,000	44,149,000
Total Assets	1,263,407,000	1,311,999,000	1,495,331,000	1,496,020,000	1,594,920,000
Total Current Liabilities	287,037,000	309,822,000	393,492,000	358,918,000	357,103,000
Total Equity	444,123,000	601,190,000	738,180,000	739,237,000	774,650,000
Free Cash Flow	28,929,000	162,038,000	184,152,000	10,173,000	1,691,000
Cash from Operations	111,847,000	218,849,000	273,601,000	117,550,000	135,413,000
Cash from Investing	-84,103,000	-67,562,000	-189,273,000	-110,897,000	-142,902,000
Cash from Financing	-24,188,000	-146,793,000	-68,443,000	-7,870,000	-2,715,000
Net Change in Cash	3,556,000	4,494,000	15,885,000	-1,217,000	-10,204,000